A real-world disproportionality analysis of tirzepatide-related adverse events based on the FDA Adverse Event Reporting System (FAERS) database

• 資料種別: 記事
• タイトル: A real-world disproportionality analysis of tirzepatide-related adverse events based on the FDA Adverse Event Reporting System (FAERS) database
• 巻次・部編番号: 72; 3
• 著者・編者: Li Jie; Xie Jun; Han Yi; Zhang Wei; Wang Yilei; Jiang Zhitao
• 著者標目: Li Jie; Xie Jun; Han Yi; Zhang Wei; Wang Yilei; Jiang Zhitao
• 出版年月日等: 2025
• 出版年（W3CDTF）: 2025
• タイトル（掲載誌）: Endocrine Journal
• 巻号年月日等（掲載誌）: 72 3
• 掲載巻: 72
• 掲載号: 3
• 掲載ページ: 273-283
• ISSN（掲載誌）: 0918-8959; 1348-4540
• ISSN-L（掲載誌）: 0918-8959
• 件名標目: Adverse drug event; FDA Adverse Event Reporting System (FAERS); Disproportionality analysis; GIP/GLP-1 RA; Tirzepatide
• 対象利用者: 一般
• DOI: 10.1507/endocrj.EJ24-0286
• オンライン閲覧公開範囲: インターネット公開
• 連携機関・データベース: 科学技術振興機構 : J-STAGE; http://www.jstage.jst.go.jp

• 要約等: <p>Tirzepatide is a novel drug for the treatment of type 2 diabetes mellitus and chronic weight management, and there is an urgent need to explore its...